← Back to Search

Ureteral Stent

Memokath 051 Ureteral Stent for Ureteral Obstruction

N/A
Waitlist Available
Led By Lance A Mynderse, M.D.
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 59 months after placement of stent
Awards & highlights
No Placebo-Only Group

Summary

The purpose of this study is to evaluate the safety and efficacy of the Memokath 051 ureteral stent as a long-term temporary and minimally invasive means of providing ureteral drainage in the setting of malignant extrinsic ureteral obstruction secondary to inoperable abdominal or pelvic malignancies. Up to 15 adults who have extrinsic ureteral obstruction secondary to an inoperable abdominal or pelvic malignancy and need ureteral stent drainage will undergo outpatient placement of the ureteral stent. Ongoing monitoring will continue for as long as the stent is in place.

Eligible Conditions
  • Ureteral Obstruction

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 59 months after placement of stent
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 59 months after placement of stent for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Mean Stent Dwell Time

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Memokath 051 Ureteral StentExperimental Treatment1 Intervention
Subjects assigned to this arm received a Memokath 051 Ureteral Stent.
Group II: JJ StentActive Control1 Intervention
Subjects assigned to this arm received a JJ stent.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Memokath 051 Ureteral Stent
2004
N/A
~30

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,344 Previous Clinical Trials
3,062,374 Total Patients Enrolled
Pnn Medical A/SIndustry Sponsor
2 Previous Clinical Trials
164 Total Patients Enrolled
Lance A Mynderse, M.D.Principal InvestigatorMayo Clinic
~1 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top